Migraine Drugs Market by Competitive Analysis and Clinical Research Analysis 2020 to 2030
The Global Migraine Drugs Market size was valued at USD 1.80 billion in 2019 and is predicted to reach USD 2.44 billion by 2030, with a CAGR of 2.8% from 2020-2030.
Migraine is a medical condition pertaining
with primary headache disorder with symptoms such as nausea, vomiting, dry
mouth, somnolence, and sensitivity to light or sound. The headaches start from
one side of the head and are pulsating in nature. In some cases, patients are affected
by prevalence of aura. The recurrent headaches can last up to some hours or
days, with intensity varying from moderate to severe. Migraine has no permanent
cure, but migraine drugs can be used to reduce and prevent migraines.
Access
Full Description of this report at:-
https://www.nextmsc.com/report/migraine-drugs-market
Top Companies: Allergan Plc, Abbott Laboratories,
AstraZeneca, Endo International Plc., Eisai Co. Ltd., Impax Laboratories,
GlaxoSmithKline Plc., Johnson & Johnson, Pfizer Inc., Merck & Co., Teva
Pharmaceutical Industries Limited, Sanofi SA and others.
According to the data
provided by Migraine Trust in 2017, 1 in 7 people worldwide suffer from
migraine, i.e. 2% of the total world population suffer from migraine; thereby,
migraine being the third most common disease at global level. This scenario
generates a demand for effective migraine drugs with minimal or no
side-effects; hence supplementing the growth of migraine drugs market. However,
side effects associated with the intake of migraine drugs are expected to
restrict the growth of migraine drugs market.
Request sample copy of this report
at:-
https://www.nextmsc.com/Migraine-Drugs-Market/request-sample
The
global migraine drugs market share has been analyzed based on type, route of
administration, distribution channel and geography. Based on type, the migraine
drugs market is segmented into preventive medicine and abortive medicine. The
abortive medicine segment is sub segmented into Triptans (Serotonin Receptor
Agonists), Ergotamine Derivative, and others. The preventive medicine is
further divided into Anticonvulsant, Antidepressant, Beta Blocker, and others.
Based on distribution channel, the migraine drugs market is divided into
hospital-based pharmacies, retail pharmacies, and online pharmacies. Geographic
breakdown and analysis of each of the previously mentioned segments include
regions comprising North America, Europe, Asia-Pacific, and RoW.
About
Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and
trusted third-platform market intelligence provider, committed to deliver high
quality, market research reports that help multinational companies to triumph
over their competitions and increase industry footprint by capturing greater
market share. Our research model is a unique collaboration of primary research,
secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally
that includes 90% of the Fortune 500 companies over a decade. Our analysts are
constantly tracking various high growth markets and identifying hidden
opportunities in each sector or the industry. We provide one of the industry’s
best quality syndicate as well as custom research reports across 10 different
industry verticals. We are committed to deliver high quality research solutions
in accordance to your business needs. Our industry standard delivery solution
that ranges from the pre consultation to after-sales services, provide an
excellent client experience and ensure right strategic decision making for
businesses.
For more insights, please visit, https://www.nextmsc.com
Comments
Post a Comment